Home › Investors short Juno Therapeutics, Amgen stocks, but that may not be bad news
 

Keywords :   


Investors short Juno Therapeutics, Amgen stocks, but that may not be bad news

2015-03-03 04:12:21| Biotech - Topix.net

More investors were shorting their biotech stocks in the first half of February than in the previous month, according to financial news site Benzinga . Of the top three companies with the most short sells, two have Puget Sound ties: Seattle-based Juno Therapeutics and California-based Amgen , which has offices in Bothell and Seattle until the end of the year.

Tags: news short bad stocks

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
04.07Hurricane Beryl Graphics
04.07Hurricane Beryl Forecast Discussion Number 25
04.07Hurricane Beryl Public Advisory Number 25
04.07Summary for Hurricane Beryl (AT2/AL022024)
04.07Hurricane Beryl Wind Speed Probabilities Number 25
04.07Hurricane Beryl Forecast Advisory Number 25
04.07Tropical Storm Aletta Graphics
04.07Tropical Storm Aletta Forecast Discussion Number 2
More »